RT Journal Article
SR Electronic
A1 Rizzo, Toni
T1 IMPROVE-IT Findings
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 28
SP 21
OP 22
DO 10.1177/1559897715611882
UL http://mdc.sagepub.com/content/15/28/21.abstract
AB The IMPROVE-IT trial showed that the cholesterol-lowering drug ezetimibe, when added to simvastatin, provides greater improvement in cardiovascular outcomes among patients with diabetes vs those without diabetes in a population with acute coronary syndrome. Additionally, the rate of new-onset diabetes was not increased among patients treated with ezetimibe.